Your browser doesn't support javascript.
loading
Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa, Roopa Hebbandi; Wang, Rong; Xie, Yufeng; Umeshappa, Channakeshava Sokke; Xiang, Jim.
Affiliation
  • Nanjundappa RH; Cancer Research Unit, Saskatchewan Cancer Agency, Division of Oncology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Vaccine ; 30(24): 3519-25, 2012 May 21.
Article in En | MEDLINE | ID: mdl-22484292
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / HIV Envelope Protein gp120 / HIV Infections / AIDS Vaccines / CD8-Positive T-Lymphocytes / Immunotherapy Limits: Animals / Humans Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Canada Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / HIV Envelope Protein gp120 / HIV Infections / AIDS Vaccines / CD8-Positive T-Lymphocytes / Immunotherapy Limits: Animals / Humans Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Canada Country of publication: Netherlands